Exact Therapeutics AS (OSL:EXTX) Change In Receivables : kr-1.33 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Change In Receivables?

Exact Therapeutics AS's change in receivables for the quarter that ended in Dec. 2023 was kr-0.02 Mil. It means Exact Therapeutics AS's Accounts Receivable increased by kr0.02 Mil from Jun. 2023 to Dec. 2023 .

Exact Therapeutics AS's change in receivables for the fiscal year that ended in Dec. 2023 was kr-1.33 Mil. It means Exact Therapeutics AS's Accounts Receivable increased by kr1.33 Mil from Dec. 2022 to Dec. 2023 .

Exact Therapeutics AS's Accounts Receivable for the quarter that ended in Dec. 2023 was kr0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Exact Therapeutics AS's liquidation value for the six months ended in Dec. 2023 was kr29.36 Mil.

Exact Therapeutics AS Change In Receivables Historical Data

The historical data trend for Exact Therapeutics AS's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Change In Receivables Chart

Exact Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-1.24

-0.90

-1.62

-0.53

-1.33

Exact Therapeutics AS Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial						2.39	-1.37	0.83	-1.31	-0.02

Exact Therapeutics AS Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-1.33 Mil.

Exact Therapeutics AS (OSL:EXTX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Exact Therapeutics AS's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Exact Therapeutics AS's accounts receivable are only considered to be worth 75% of book value:

Exact Therapeutics AS's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	45.573	-	16.218	+	0.75 * 0	+	0.5 * 0
=	29.36

Exact Therapeutics AS Change In Receivables Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Therapeutics AS (OSL:EXTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostre Aker vei 19, Oslo, NOR, 0581

Website

https://www.exact-tx.com

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines